Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS): A Randomized, Double-Blind, Placebo Controlled Proof-of-Concept Clinical Trial.

NCT00336466 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT00336466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00336466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS): A Randomized, Double-Blind, Placebo Controlled Proof-of-Concept Clinical Trial.
Lead sponsor
University of Calgary
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2004
Completion date
May 31, 2005
Enrollment
32
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain injury, cardiac surgery